Proposed Data Collection Submitted for Public Comment and Recommendations, 50122-50124 [2021-19162]
Download as PDF
<![CDATA[
50122
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
• Closing Remarks
Ken Ambrose,
Senior Advisor CDO Council, Office of Shared
Solutions and Performance Improvement,
General Services Administration.
Shenaye Holmes,
Senior Advisor CDO Council, Office of Shared
Solutions and Performance Improvement,
General Services Administration.
[FR Doc. 2021–19227 Filed 9–3–21; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
(Authority: 42 U.S.C. 7384q(b). 42 U.S.C.
7384l(14)(C))
Centers for Disease Control and
Prevention
Frank J. Hearl,
Chief of Staff, National Institute for
Occupational Safety and Health.
Designation of a Class of Employees
for Addition to the Special Exposure
Cohort
[FR Doc. 2021–19167 Filed 9–3–21; 8:45 am]
BILLING CODE 4163–18–P
sradovich on DSKJLST7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
HHS gives notice of a
decision to designate a class of
employees from the Savannah River Site
in Aiken, South Carolina, as an addition
to the Special Exposure Cohort (SEC)
under the Energy Employees
Occupational Illness Compensation
Program Act of 2000.
FOR FURTHER INFORMATION CONTACT:
Grady Calhoun, Director, Division of
Compensation Analysis and Support,
NIOSH, 1090 Tusculum Avenue, MS C–
46, Cincinnati, OH 45226–1938,
Telephone 1–877–222–7570.
Information requests can also be
submitted by email to DCAS@CDC.GOV.
SUPPLEMENTARY INFORMATION: On August
18, 2021, as provided for under 42
U.S.C. 7384l(14)(C), the Secretary of
HHS designated the following class of
employees as an addition to the SEC:
‘‘All construction trade employees of
Department of Energy subcontractors
[excluding employees of the following
prime contractors who worked at the
Savannah River Site in Aiken, South
Carolina, during the specified time
periods: E. I. du Pont de Nemours and
Company, October 1, 1972, through
March 31, 1989; and Westinghouse
Savannah River Company, April 1,
1989, through December 31, 1990], who
worked at the Savannah River Site from
October 1, 1972, through December 31,
1990, for a number of work days
aggregating at least 250 work days,
occurring either solely under this
employment or in combination with
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
period from January 1, 1952, through
December 31, 1957.’’
(Authority: 42 U.S.C.7384q.)
Frank J. Hearl,
Chief of Staff, National Institute for
Occupational Safety and Health.
[FR Doc. 2021–19166 Filed 9–3–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0920; Docket No. CDC–2021–
0092]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
SUMMARY:
work days within the parameters
established for one or more other classes
of employees included in the Special
Exposure Cohort.’’
This designation will become
effective on September 17, 2021, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
Determination Concerning a Petition
To Add a Class of Employees to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
HHS gives notice of a
determination concerning a petition to
add a class of employees from Superior
Steel Company, in Carnegie,
Pennsylvania, to the Special Exposure
Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000
(EEOICPA).
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Grady Calhoun, Director, Division of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 1090
Tusculum Avenue, MS C–45,
Cincinnati, OH 45226–1938, Telephone
1–877–222–7570. Information requests
can also be submitted by email to
DCAS@CDC.GOV.
SUPPLEMENTARY INFORMATION: On August
19, 2021, the Secretary of HHS
determined that the following class of
employees does not meet the statutory
criteria for addition to the SEC as
authorized under EEOICPA:
‘‘All atomic weapons employees who
worked in any area at Superior Steel Co.
in Carnegie, Pennsylvania, during the
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Data Collection Through Web
Based Surveys for Evaluating Act
Against AIDS Social Marketing
Campaign Phases Targeting Consumers.
This proposed information collection
activity includes the use of web surveys
to test campaign messaging.
DATES: CDC must receive written
comments on or before November 8,
2021.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0092 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the Agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
ADDRESSES:
07SEN1
50123
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
through surveys with consumers. A total
of 6,445 respondents were approved for
the previously renewed Generic ICR
(0920–0920) in 2018, and since the
approval date, 1,000 respondents were
surveyed under the GenIC,
‘‘Development of Messages for the Let’s
Stop HIV Together National Campaign’’.
The information collected from this
survey was used to evaluate the
acceptability and potential effectiveness
of proposed concepts, messages, and
taglines for a component of the Let’s
Stop HIV Together campaign focused on
HIV prevention that promotes proven,
effective prevention strategies, such as
pre-exposure prophylaxis (PrEP) and
treatment as prevention (TasP).
CDC is requesting a one-year
extension to continue surveying target
audiences. Through this extension, we
plan to reach the remaining approved
5,445 respondents. To obtain the
remaining respondents, we anticipate
screening approximately 30,880
individuals. Depending on the target
audience for the campaign phase, the
study screener will vary. The study
screener may address one or more of the
following items: Race/ethnicity, sexual
behavior, sexual orientation, gender
identity, HIV testing history, HIV status,
and injection drug use. Each survey will
have a core set of items asked in all
rounds, as well as a module of questions
relating to specific Let’s Stop HIV
Together phases and activities.
Respondents will be recruited through
national opt-in email lists, the internet,
and external partnerships with
community-based and membership
organizations that work with or
represent individuals from targeted
populations (e.g., National Urban
League, the National Medical
Association). Respondents will selfadminister the survey at home on
personal computers. In total CDC
requests approval for an estimated 3,751
burden hours. There is no cost to the
respondents other than their time.
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Data Collection Through Web Based
Surveys for Evaluating Act Against
AIDS Social Marketing Campaign
Phases Targeting Consumers (OMB
Control No. 0920–0920, Exp. 11/30/
2021)—Extension — National Center for
HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV
epidemic in our country, CDC launched
the Let’s Stop HIV Together campaign
(formerly known as Act Against AIDS),
a multifaceted communication
campaign to reduce HIV incidence in
the United States in 2009. CDC has
released the campaign in phases, with
some of the phases running
concurrently. Each phase of the
campaign uses mass media and directto-consumer channels to deliver
messages. Some campaigns provide
basic education and increase awareness
of HIV/AIDS among the general public
whereas others emphasize HIV
prevention and testing among specific
subgroups or communities at greatest
risk of infection. CDC will also develop
new messages to address changes in
prevention science and subpopulations
affected by HIV. The proposed study
will assess the effectiveness of these
social marketing messages aimed at
increasing HIV/AIDS awareness,
increasing prevention behaviors, and
improving HIV testing rates among
consumers.
This Extension of an ongoing study
will allow for continued evaluation of
the effectiveness of Let’s Stop HIV
Together social marketing campaign
sradovich on DSKJLST7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hr)
Total burden
(in hr)
Type of respondent
Form name
Individuals (male and female) aged 18 years and
older.
Study Screener .............
Survey Module .............
30,880
5,445
1
1
2/60
30/60
1,029
2,722
Total ...............................................................
.......................................
........................
........................
........................
3,751
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
U:\07SEN1.SGM
07SEN1
50124
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–19162 Filed 9–3–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1092; Docket No. CDC–2021–
0091]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Sudden Death in the Young
(SDY). The goal of the SDY Case
Registry is to improve and standardize
the ascertainment of deaths so that
funded jurisdictions can better
understand the incidence and risk
factors for sudden death in youth. Per
CDC’s cooperative agreement,
respondents agree to compile a defined
set of SDY information about a defined
subset of child deaths through the
jurisdiction/state’s existing CDR
program.
DATES: CDC must receive written
comments on or before November 8,
2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0091 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
sradovich on DSKJLST7X2PROD with NOTICES
SUMMARY:
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
Proposed Project
Sudden Death in the Young (SDY)
(OMB Control No. 0920–1092, Exp. 04/
30/2022)—Extension—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC)
Background and Brief Description
Estimates of the annual incidence of
sudden death in the young (SDY) vary
broadly due to differences in case
definitions, inconsistencies in
classifying cause of death (on death
certificates), study populations, and
case ascertainment. To address the need
for improved estimates of SDY
incidence, and its epidemiology based
on uniform cases definitions, CDC, in
collaboration with NIH’s National Heart,
Lung, and Blood Institute (NHLBI) and
National Institute of Neurological
Disorders and Stroke (NINDS),
implemented the SDY Case Registry in
2015. To meet the ongoing need to
produce accurate and uniform
information, CDC and NIH continued
the SDY Case Registry in 2018 with 13
awardees through a CDC-based
cooperative agreement program (DP18–
1806).
CDC awardees agree to compile a
defined set of SDY information about a
defined subset of child deaths through
the jurisdiction/state’s existing CDR
program. Each of the 13 CDC-funded
jurisdiction/state awardees will, on
average, review and enter data on 55 of
720 cases each year. Additionally, based
on historical program information, it is
estimated that approximately half (360)
of the 720 estimated SDY cases each
year will be recommended for advanced
clinical review by a team of three
medical experts.
OMB approval is requested for three
years. The total estimated annual
burden is 511 hours. There are no costs
to respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State health personnel ..........................................
SDY Module I ...............
VerDate Sep<11>2014
00:30 Sep 04, 2021
Jkt 253001
PO 00000
Frm 00113
Fmt 4703
I
Sfmt 4703
13
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Type of respondent
I
U:\07SEN1.SGM
55
07SEN1
I
10/60
Total burden
hours
119
]]>Agencies
[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50122-50124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19162]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0920; Docket No. CDC-2021-0092]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Data Collection Through Web Based
Surveys for Evaluating Act Against AIDS Social Marketing Campaign
Phases Targeting Consumers. This proposed information collection
activity includes the use of web surveys to test campaign messaging.
DATES: CDC must receive written comments on or before November 8, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0092 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the Agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal
[[Page 50123]]
(regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Data Collection Through Web Based Surveys for Evaluating Act
Against AIDS Social Marketing Campaign Phases Targeting Consumers (OMB
Control No. 0920-0920, Exp. 11/30/2021)--Extension -- National Center
for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV epidemic in our country, CDC
launched the Let's Stop HIV Together campaign (formerly known as Act
Against AIDS), a multifaceted communication campaign to reduce HIV
incidence in the United States in 2009. CDC has released the campaign
in phases, with some of the phases running concurrently. Each phase of
the campaign uses mass media and direct-to-consumer channels to deliver
messages. Some campaigns provide basic education and increase awareness
of HIV/AIDS among the general public whereas others emphasize HIV
prevention and testing among specific subgroups or communities at
greatest risk of infection. CDC will also develop new messages to
address changes in prevention science and subpopulations affected by
HIV. The proposed study will assess the effectiveness of these social
marketing messages aimed at increasing HIV/AIDS awareness, increasing
prevention behaviors, and improving HIV testing rates among consumers.
This Extension of an ongoing study will allow for continued
evaluation of the effectiveness of Let's Stop HIV Together social
marketing campaign through surveys with consumers. A total of 6,445
respondents were approved for the previously renewed Generic ICR (0920-
0920) in 2018, and since the approval date, 1,000 respondents were
surveyed under the GenIC, ``Development of Messages for the Let's Stop
HIV Together National Campaign''. The information collected from this
survey was used to evaluate the acceptability and potential
effectiveness of proposed concepts, messages, and taglines for a
component of the Let's Stop HIV Together campaign focused on HIV
prevention that promotes proven, effective prevention strategies, such
as pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP).
CDC is requesting a one-year extension to continue surveying target
audiences. Through this extension, we plan to reach the remaining
approved 5,445 respondents. To obtain the remaining respondents, we
anticipate screening approximately 30,880 individuals. Depending on the
target audience for the campaign phase, the study screener will vary.
The study screener may address one or more of the following items:
Race/ethnicity, sexual behavior, sexual orientation, gender identity,
HIV testing history, HIV status, and injection drug use. Each survey
will have a core set of items asked in all rounds, as well as a module
of questions relating to specific Let's Stop HIV Together phases and
activities.
Respondents will be recruited through national opt-in email lists,
the internet, and external partnerships with community-based and
membership organizations that work with or represent individuals from
targeted populations (e.g., National Urban League, the National Medical
Association). Respondents will self-administer the survey at home on
personal computers. In total CDC requests approval for an estimated
3,751 burden hours. There is no cost to the respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female) Study Screener.. 30,880 1 2/60 1,029
aged 18 years and older. Survey Module... 5,445 1 30/60 2,722
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,751
----------------------------------------------------------------------------------------------------------------
[[Page 50124]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-19162 Filed 9-3-21; 8:45 am]
BILLING CODE 4163-18-P
